- Record: found
- Abstract: found
- Article: found
Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.
François Laliberté
1 ,
Michel Cloutier
2 ,
Concetta Crivera
3 ,
Winnie W Nelson
3 ,
William H Olson
3 ,
Jeffrey Schein
3 ,
Julie Vanderpoel
3 ,
Guillaume Germain
2 ,
Patrick Lefebvre
2
Mar 1 2015
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Compared with warfarin, the new target-specific oral anticoagulant agents may have advantages, such as shorter hospital length of stay, in patients with nonvalvular atrial fibrillation (NVAF). The objective of the present study was to assess, among patients with NVAF, the effects of rivaroxaban versus warfarin on the number of hospitalization days and other health care resource utilization in a cohort of rivaroxaban users and matched warfarin users.